Why the study?
Low HDL levels are associated with increased stroke incidence and worsened outcomes, but their relationship with long-term stroke outcomes in the Arab population required assessment.
Does low HDL level increase the risk of stroke recurrence and major adverse cardiovascular events in Arab patients with ischemic stroke?
Does low HDL level increase the risk of stroke recurrence and major adverse cardiovascular events in Arab patients with ischemic stroke?
In Arab patients with ischemic stroke, low HDL levels are independently associated with a significantly higher risk of 1-year stroke recurrence and major adverse cardiovascular events.
May warrant closer monitoring in Arab ischemic stroke patients; leaves open whether HDL-targeted interventions improve outcomes in this population.
Low HDL levels are associated with an increased stroke incidence and worsened long-term outcomes. The aim of this study was to assess the relationship between HDL levels and long-term stroke outcomes in the Arab population. Patients admitted to the Qatar Stroke Database between 2014 and 2022 were included in the study and stratified into sex-specific HDL quartiles. Long-term outcomes included 90-Day modified Rankin Score (mRS), stroke recurrence, and post-stroke cardiovascular complications within 1 year of discharge. Multivariate binary logistic regression analyses were performed to identify the independent effect of HDL levels on short- and long-term outcomes. On multivariate binary logistic regression analyses, 1-year stroke recurrence was 2.24 times higher (p = 0.034) and MACE was 1.99 times higher (p = 0.009) in the low-HDL compared to the high-HDL group. Mortality at 1 year was 2.27-fold in the low-normal HDL group compared to the reference group (p = 0.049). Lower sex-specific HDL levels were independently associated with higher adjusted odds of 1-year post-stroke mortality, stroke recurrence, and MACE (p < 0.05). In patients who suffer a stroke, low HDL levels are associated with a higher risk of subsequent vascular complication.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: